During the past decade, Samodzielny Publiczny Szpital Kliniczny nr 1 conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samodzielny Publiczny Szpital Kliniczny nr 1" #1 sponsor was "Medical University of Silesia" with 8 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samodzielny Publiczny Szpital Kliniczny nr 1" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator and "Vanderbilt University Medical Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Samodzielny Publiczny Szpital Kliniczny nr 1" are "Predictive Value of Tests" (4 trials), "Anesthesia, Conduction" (2 trials), "Lung Diseases, Interstitial" (2 trials), "Multiple Sclerosis" (2 trials) and "Airway Management" (1 trials). Many other conditions were trialed in "Samodzielny Publiczny Szpital Kliniczny nr 1" in a lesser frequency.

Most popular intervention types in "Samodzielny Publiczny Szpital Kliniczny nr 1" are "Drug" (9 trials), "Diagnostic Test" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Mavenclad®" (2 trials), "Nintedanib" (2 trials), "Anthropometric measurements during routine preoperative visit" (1 trials) and "Assesment of intubation parameters during induction of general anaesthesia" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samodzielny Publiczny Szpital Kliniczny nr 1" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Samodzielny Publiczny Szpital Kliniczny nr 1". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Samodzielny Publiczny Szpital Kliniczny nr 1, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Samodzielny Publiczny Szpital Kliniczny nr 1, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Samodzielny Publiczny Szpital Kliniczny nr 1 has several departments that took part in Clinical trials: "Szpital Kliniczny nr 1 im. prof. Szyszko; Oddz. Nefrologii Dzieciecej z Pododdziałem Dializoterapii" - 3 trials, "SPSK nr 1; Klinika Neurologii" - 3 trials